Terms: = Gastric cancer AND NSD1, FLJ44628, 64324, ENSG00000165671, Q96L73, FLJ22263, DKFZp666C163, ARA267, STO, SOTOS
27 results:
1. Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy.
Masetti M; Al-Batran SE; Goetze TO; Thuss-Patience P; Knorrenschild JR; Goekkurt E; Folprecht G; Ettrich TJ; Lindig U; Luley KB; Pink D; Dechow T; Sookthai D; Junge S; Loose M; Pauligk C; Lorenzen S
Int J Cancer; 2024 Jun; 154(12):2142-2150. PubMed ID: 38447003
[TBL] [Abstract] [Full Text] [Related]
2. Serum extracellular vesicles with nsd1 and FBXO7 mRNA as novel biomarkers for gastric cancer.
Wang Z; Ding J; Xiao Y; Xiao K; Su P; Dong Z; Zhang Y
Clin Biochem; 2023 Oct; 120():110653. PubMed ID: 37742869
[TBL] [Abstract] [Full Text] [Related]
3. The epigenetic modifier lysine methyltransferase 2C is frequently mutated in gastric remnant carcinoma.
Sun B; Chen H; Lao J; Tan C; Zhang Y; Shao Z; Xu D
J Pathol Clin Res; 2023 Sep; 9(5):409-422. PubMed ID: 37395342
[TBL] [Abstract] [Full Text] [Related]
4. Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-sto-0415).
Lorenzen S; Schwarz A; Pauligk C; Goekkurt E; Stocker G; Knorrenschild JR; Illerhaus G; Dechow T; Moehler M; Moulin JC; Pink D; Stahl M; Schaaf M; Goetze TO; Al-Batran SE
BMC Cancer; 2023 Jun; 23(1):561. PubMed ID: 37337155
[TBL] [Abstract] [Full Text] [Related]
5. [Clinicopathological features of
Hou WH; Song SJ; Shi ZY; Jin ML
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):292-298. PubMed ID: 37042140
[TBL] [Abstract] [Full Text] [Related]
6. Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data.
Li M; Gao X; Wang X
Front Immunol; 2023; 14():1090838. PubMed ID: 36911742
[TBL] [Abstract] [Full Text] [Related]
7. The impact of the 30-day postoperative complications on the quality of life following gastrectomy for gastric carcinoma: A prospective study.
Jang A; Jeong O
Eur J Surg Oncol; 2023 May; 49(5):983-989. PubMed ID: 36682945
[TBL] [Abstract] [Full Text] [Related]
8. Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase-II study-The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-sto-0510.
Högner A; Al-Batran SE; Siveke JT; Lorenz M; Bartels P; Breithaupt K; Malfertheiner P; Homann N; Stein A; Gläser D; Tamm I; Hinke A; Vogel A; Thuss-Patience P;
Int J Cancer; 2022 Mar; 150(6):1007-1017. PubMed ID: 34741530
[TBL] [Abstract] [Full Text] [Related]
9. Hyperactivation of MEK/ERK pathway by Ca
Najar MA; Aravind A; Dagamajalu S; Sidransky D; Ashktorab H; Smoot DT; Gowda H; Prasad TSK; Modi PK; Chatterjee A
Mol Carcinog; 2021 Nov; 60(11):769-783. PubMed ID: 34437731
[TBL] [Abstract] [Full Text] [Related]
10. Health-related quality of life after curative resection for gastric adenocarcinoma.
Grosek J; Zavrtanik H; Tomažič A
World J Gastroenterol; 2021 Apr; 27(16):1816-1827. PubMed ID: 33967559
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of nutrition and quality of life of esophagogastrostomy and the double-tract reconstruction after laparoscopic proximal gastrectomy.
Eom BW; Park JY; Park KB; Yoon HM; Kwon OK; Ryu KW; Kim YW
Medicine (Baltimore); 2021 Apr; 100(15):e25453. PubMed ID: 33847651
[TBL] [Abstract] [Full Text] [Related]
12. Molecular Profiling Associated with Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2)-Mediated Carcinogenesis in gastric cancer.
Najar MA; Modi PK; Ramesh P; Sidransky D; Gowda H; Prasad TSK; Chatterjee A
J Proteome Res; 2021 May; 20(5):2687-2703. PubMed ID: 33844560
[TBL] [Abstract] [Full Text] [Related]
13. Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic Esophagogastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO sto 0217).
Tintelnot J; Goekkurt E; Binder M; Thuss-Patience P; Lorenzen S; Knorrenschild JR; Kretzschmar A; Ettrich T; Lindig U; Jacobasch L; Pink D; Al-Batran SE; Hinke A; Hegewisch-Becker S; Nilsson S; Bokemeyer C; Stein A
BMC Cancer; 2020 Jun; 20(1):503. PubMed ID: 32487035
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of hyperspectral imaging (HSI) for the measurement of ischemic conditioning effects of the gastric conduit during esophagectomy.
Köhler H; Jansen-Winkeln B; Maktabi M; Barberio M; Takoh J; Holfert N; Moulla Y; Niebisch S; Diana M; Neumuth T; Rabe SM; Chalopin C; Melzer A; Gockel I
Surg Endosc; 2019 Nov; 33(11):3775-3782. PubMed ID: 30675658
[TBL] [Abstract] [Full Text] [Related]
15. Prospective comparative study of endoscopic submucosal dissection and gastrectomy for early neoplastic lesions including patients' perspectives.
Libânio D; Braga V; Ferraz S; Castro R; Lage J; Pita I; Ribeiro C; Abreu De Sousa J; Dinis-Ribeiro M; Pimentel-Nunes P
Endoscopy; 2019 Jan; 51(1):30-39. PubMed ID: 29969807
[TBL] [Abstract] [Full Text] [Related]
16. Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German cancer Society (AIO/CAO sto-0801).
Stahl M; Maderer A; Lordick F; Mihaljevic AL; Kanzler S; Hoehler T; Thuss-Patience P; Mönig S; Kunzmann V; Schroll S; Sandermann A; Tannapfel A; Meyer HJ; Schuhmacher C; Wilke H; Moehler M;
Eur J Cancer; 2018 Apr; 93():119-126. PubMed ID: 29501977
[TBL] [Abstract] [Full Text] [Related]
17. Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer.
Korkeila EA; Salminen T; Kallio R; Mikkola M; Auvinen P; Pyrhönen S; Ristamäki R
Support Care Cancer; 2017 Sep; 25(9):2771-2777. PubMed ID: 28424889
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of the EORTC sto-22 and the FACT-Ga quality of life questionnaires for patients with gastric cancer.
Woo A; Fu T; Popovic M; Chow E; Cella D; Wong CS; Lam H; Pulenzas N; Lechner B; Vuong S; Ganesh V; Bottomley A
Ann Palliat Med; 2016 Jan; 5(1):13-21. PubMed ID: 26841811
[TBL] [Abstract] [Full Text] [Related]
19. Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy.
Katoh M
Epigenomics; 2016 Feb; 8(2):285-305. PubMed ID: 26411517
[TBL] [Abstract] [Full Text] [Related]
20. [Cultural adaptation and psychometric validation of the health-related quality of life questionnaire EORTC QLQ sto-22 for patients with gastric cancer in Peru].
Soria Moncada JM; Carrasco Lozano JG; Loza Munarriz C; Ruiz Figueroa E; Payet Meza E
Rev Gastroenterol Peru; 2015; 35(2):127-35. PubMed ID: 26228978
[TBL] [Abstract] [Full Text] [Related]
[Next]
